Skip to main content
Clinical Trials/NL-OMON29089
NL-OMON29089
Recruiting
Not Applicable

Outcomes for patients undergoing endoscopic therapy for Barrett’s related neoplasia: over 10-year experience from the Dutch Barrett Expert Centers

ead site:Academic Medical Center Amsterdam (AMC)Collaborating centers:•Sint Antonius Hospital Nieuwegein•Catharina Hospital, Eindhoven•University Medical Center, Utrecht•Isala Clinics, Zwolle•Erasmus Medical Center, Rotterdam•Haga Hospital, Den Haag•University Medical Center, Groningen0 sites2,000 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Barrett's esophagus
Sponsor
ead site:Academic Medical Center Amsterdam (AMC)Collaborating centers:•Sint Antonius Hospital Nieuwegein•Catharina Hospital, Eindhoven•University Medical Center, Utrecht•Isala Clinics, Zwolle•Erasmus Medical Center, Rotterdam•Haga Hospital, Den Haag•University Medical Center, Groningen
Enrollment
2000
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Observational non invasive

Investigators

Sponsor
ead site:Academic Medical Center Amsterdam (AMC)Collaborating centers:•Sint Antonius Hospital Nieuwegein•Catharina Hospital, Eindhoven•University Medical Center, Utrecht•Isala Clinics, Zwolle•Erasmus Medical Center, Rotterdam•Haga Hospital, Den Haag•University Medical Center, Groningen

Eligibility Criteria

Inclusion Criteria

  • 1\)Males or females, all ages
  • 2\)Presence of Barrett’s esophagus, with presence of intestinal metaplasia in histologic assessment.

Exclusion Criteria

  • 1\)Objection against participation in this study, through an opt\-out card or e\-mail
  • 2\)Referral for surgery after the work\-up endoscopy for advanced EAC

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
Retrospective Analysis of outcome after endoscopic therapy of symptomatic esophago-gastrointestinal stenoses in Patients with Crohn's disease at the Robert-Bosch-Krankenhaus Stuttgart between January 2008 and May 2018K50.0K52.3Crohn disease of small intestineIndeterminate colitis
DRKS00015906Robert Bosch Medizinische Forschung (RBMF) des Robert Bosch Krankenhaus Stuttgart163
Recruiting
Phase 4
The outcomes following Percutaneous Endoscopic Transforaminal Lumbar Interbody Fusion (PETLIF) and Minimally Invasive Transforaminal Lumbar Interbody Fusion surgery (MIS-TLIF) for the treatment of lumbar disease: a randomized controlled trialPatients who diagnosed Degenerative Lumbar disease, causing Lumbar spondylolisthesis, lumbar discherniated, Lumbar spinal stenosis.Percutaneous Endoscopic Transforaminal Lumbar Interbody Fusion, PETLIF, Endo-TLIF, Minimally Invasive Transforaminal Lumbar Interbody Fusion surgery, MIS-TLIF, TLIF, Degenerative Lumbar disease
TCTR20240708003Faculty of Medicine Ramathibodi Hospital, Mahidol University44
Recruiting
Not Applicable
Outcomes of patients who performed endoscopic sphincterotomy and delayed cholecystectomy versus same admission cholecystectomy after non-severe biliary pancreatitis
TCTR20181217001o62
Active, not recruiting
Not Applicable
Comparison of ESD outcome using different dose of PPI
KCT0004239Kyung Hee University Hospital438
Recruiting
Not Applicable
Ong-term onCologicAL outcomes of endoscopic full-thickness resection after previous incomplete resection of low-risk T1 CRCendoscopic full thickness resectioncolorectal polypT1 colorectal cancercolonoscopy
NL-OMON22704Amsterdam University Medical Center, location AMC153